Special Issue "Vaccines against Infectious Diseases: Current Research and Future Perspectives"

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Immunology and Immunotherapy".

Deadline for manuscript submissions: closed (30 November 2023) | Viewed by 83

Special Issue Editor

Dr. Ebony Gary
E-Mail Website
Guest Editor
The Wistar Institute, 3601 Spruce St., Philadelphia, PA 19104, USA
Interests: nucleic acid vaccines; adjuvants; infectious diseases; respiratory viral vaccines; mucosal immunity

Special Issue Information

Dear Colleagues,

Novel vaccine platforms and delivery systems, including nucleic acid vaccines, viral-vectored vaccines and adjuvant-enhanced protein-based vaccines, have the potential to enhance immunity in clinical and preclinical studies. Despite this, generating robust de-novo immunity at mucosal surfaces, where a large portion of infections occur, remains a challenge. Similarly, generating robust, long-lived, protective immunity in aged patient populations is a hurdle that all platforms must overcome. This Special Issue will focus on novel vaccine platforms, delivery systems, and the inclusion of adjuvants to enhance vaccine-induced immunity. We encourage the submission of research focusing on vaccine-induced immunity in clinical and preclinical models. We welcome the submission of original research and review articles that cover, but are not limited to, the following sub-topics:

  • Development of clinical models that recapitulate age-associated changes in vaccine-induced immunity.
  • Novel adjuvants and/or delivery methods that promote robust mucosal immune responses.
  • Immunological characterization of the correlates of vaccine-induced immunity and protection in clinical or preclinical settings.

Dr. Ebony Gary
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • infectious disease
  • vaccine
  • respiratory virus
  • adjuvant
  • mucosal immunity

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop